135 related articles for article (PubMed ID: 647307)
1. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.
Amos RS; Crockson RA; Crockson AP; Walsh L; McConkey B
Br Med J; 1978 May; 1(6124):1396. PubMed ID: 647307
[No Abstract] [Full Text] [Related]
2. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.
Walsh L; Davies P; McConkey B
Ann Rheum Dis; 1979 Aug; 38(4):362-3. PubMed ID: 496450
[TBL] [Abstract][Full Text] [Related]
3. It is said that elevated erythrocyte sedimentation rate and the elevation of C-reactive protein (CRP) may be indicators of continuing joint destruction in rheumatoid arthritis. What then is the explanation for joint destruction in some patients in whom there is no such apparent elevation of either the sedimentation rate of CRP?
McConkey B
Br J Rheumatol; 1990 Apr; 29(2):88. PubMed ID: 2322779
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction].
Silva I; Mateus M; Branco JC
Acta Reumatol Port; 2010; 35(5):456-62. PubMed ID: 21245814
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
Amos RS; Constable TJ; Crockson RA; Crockson AP; McConkey B
Br Med J; 1977 Jan; 1(6055):195-7. PubMed ID: 832072
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.
Tishler M; Caspi D; Yaron M
Clin Rheumatol; 1985 Sep; 4(3):321-4. PubMed ID: 4064588
[TBL] [Abstract][Full Text] [Related]
7. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
Vlak T; Jajić Z
Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
[TBL] [Abstract][Full Text] [Related]
8. The longterm effect of pulsed corticosteroids on the efficacy and toxicity of chrysotherapy in rheumatoid arthritis.
Heytman M; Ahern MJ; Smith MD; Roberts-Thomson PJ
J Rheumatol; 1994 Mar; 21(3):435-41. PubMed ID: 8006886
[TBL] [Abstract][Full Text] [Related]
9. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
McConkey B; Situnayake RD
J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
[TBL] [Abstract][Full Text] [Related]
10. Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate.
Skogh T; Gustafsson D; Kjellberg M; Husberg M
Ann Rheum Dis; 2003 Jul; 62(7):681-2. PubMed ID: 12810437
[No Abstract] [Full Text] [Related]
11. Sulphasalazine in rheumatoid arthritis.
McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
[TBL] [Abstract][Full Text] [Related]
12. A comparison between clinical and laboratory tests in rheumatoid arthritis.
Grindulis KA; Calverley M; Constable TJ; Forster PJ; Ahmed ME; McConkey B
Scand J Rheumatol; 1983; 12(3):285-8. PubMed ID: 6623019
[TBL] [Abstract][Full Text] [Related]
13. Can treatment really influence the radiological progression of rheumatoid arthritis?
Pullar T; Capell HA
Br J Rheumatol; 1986 Feb; 25(1):2-5. PubMed ID: 3942843
[No Abstract] [Full Text] [Related]
14. Hypercalcemia and Lytic Bone Lesions Masquerading Inflammatory Arthritis Treated as Rheumatoid Arthritis.
Salari M; Aboutorabi RB; Rezaieyazdi Z
Arch Iran Med; 2015 Oct; 18(10):720-3. PubMed ID: 26443255
[TBL] [Abstract][Full Text] [Related]
15. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate.
McConkey B; Amos RS; Billingham ME; Constable TJ; Crockson RA; Crockson AP; Forster PJ
Ann Rheum Dis; 1980 Feb; 39(1):18-21. PubMed ID: 6990881
[TBL] [Abstract][Full Text] [Related]
17. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
McCarey DW; McInnes IB; Madhok R; Hampson R; Scherbakov O; Ford I; Capell HA; Sattar N
Lancet; 2004 Jun; 363(9426):2015-21. PubMed ID: 15207950
[TBL] [Abstract][Full Text] [Related]
18. The effects of combined therapy of rheumatoid arthritis on the acute phase reactants.
Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Pllana E; Dragusha G; Gashi M; Rexhepi B
Reumatizam; 2009; 56(2):77-80. PubMed ID: 20429264
[TBL] [Abstract][Full Text] [Related]
19. Salazopyrin in rheumatoid arthritis.
McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
[TBL] [Abstract][Full Text] [Related]
20. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
